Search clinical trials for: Na-GST-1

Total 118705 results

Baylor College of Medicine
George Washington University; Children's National Research Institute

Completed

Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant

Hookworm Infection | Hookworm Disease

United States
Baylor College of Medicine

Completed

Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults

Hookworm Infection | Hookworm Disease

Brazil
Baylor College of Medicine

Completed

Study of Co-administered Na-APR-1 (M74) and Na-GST-1 in Gabonese Children

Hookworm Infection | Hookworm Disease

Gabon
Baylor College of Medicine
National Institute of Allergy and Infectious Diseases (NIAID); George Washington...

Active, not recruiting

Efficacy of Na-GST-1/Alhydrogel Hookworm Vaccine Assessed by Controlled Challenge Infection

Hookworm Infections

United States
Baylor College of Medicine
George Washington University; Amsterdam Institute for Global Health and Development and other collaborators

Completed

Na-GST-1/Alhydrogel With or Without CpG 10104 in Gabonese Adults

Hookworm Infection | Hookworm Disease

Gabon
Baylor College of Medicine
Johns Hopkins University; University of California, San Francisco; George Washington... and other collaborators

Completed

Study of Na-APR-1 (M74)/Alhydrogel® Co-administered With Na-GST-1/Alhydrogel in Brazilian Adults

Hookworm Infection | Hookworm Disease

Brazil
Baylor College of Medicine

Completed

Safety and Immunogenicity of Co-Administered Hookworm Vaccine Candidates Na-GST-1 and Na-APR-1 in Gabonese Adults

Hookworm Infection | Hookworm Disease

Gabon
Baylor College of Medicine
George Washington University

Completed

Safety and Immunogenicity Study of Na-GST-1 With or Without CpG

Hookworm Infection | Hookworm Disease

United States
NoNO Inc.
University of Calgary

Completed

Safety and Efficacy of Nerinetide (NA-1) in Subjects Undergoing Endovascular Thrombectomy for Stroke (ESCAPE-NA1)

Stroke, Acute

United States, Ireland, Korea, Republic of, Canada, Sweden, Germany, United Kingdom, Australia
Bristol-Myers Squibb

Completed

Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor

CANCER, NOS

United States
NoNO Inc.

Withdrawn

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms (ENACT-2)

Subarachnoid Hemorrhage | Ruptured Intracranial Aneurysm

Canada, United States
NoNO Inc.
Arbor Vita Corporation

Completed

Evaluating Neuroprotection in Aneurysm Coiling Therapy (ENACT)

Stroke

United States, Canada
Fujian Akeylink Biotechnology Co., Ltd.

Completed

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 Tablets

COVID-19

China
NoNO Inc.
University of British Columbia; University of Toronto; University of Calgary; Genome... and other collaborators

Completed

Field Randomization of Nerinetide (NA-1) Therapy in Early Responders (FRONTIER)

Acute Cerebral Ischemia

Canada
NoNO Inc.
University of Calgary

Completed

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (ESCAPE-NEXT)

Stroke, Acute

United States, Canada, Singapore, Netherlands, Germany, Switzerland, Australia, Norway, Italy
Rambam Health Care Campus
Israel Cancer Association

Withdrawn

Busulfan Pharmacokinetic Analysis and GST Polymorphism in Adults Undergoing Hematological Stem Cell Transplantation

Busulfan Pharmacokinetic Analysis | GST Genetic Polymorphism

Israel
Fujian Akeylink Biotechnology Co., Ltd.

Recruiting

A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B

Chronic Hepatitis B

China
Fujian Cosunter Pharmaceutical Co. Ltd

Completed

Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets

Hepatitis B

China
Meir Medical Center

Unknown

Detection of PCOS by Sensors Array

Metabolic State, Breath Analysis, NA-Nose
Albert B. Sabin Vaccine Institute
London School of Hygiene and Tropical Medicine; George Washington University; Oswaldo Cruz Foundation

Terminated

Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults

Hookworm Infection

Brazil
Fujian Akeylink Biotechnology Co., Ltd.

Recruiting

Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets

Chronic Hepatitis b

China
CONRAD
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel

Pharmacokinetics of 1% Tenofovir Gel Following Coitus | Pharmacodynamics of 1% Tenofovir Gel Following Coitus

United States
Fujian Cosunter Pharmaceutical Co. Ltd

Recruiting

Phase I Study of GST-HG151 Tablets in Healthy Volunteers

Healthy Volunteers

China
Chang Gung Memorial Hospital

Completed

EBUS-Guided TBNA Increases the Diagnostic Yield of Peripheral Pulmonary Lesions

Peripheral Pulmonary Lesions

Taiwan
Fujian Cosunter Pharmaceutical Co. Ltd

Unknown

Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets (GST-HG141)

Hepatitis B

China
Fujian Akeylink Biotechnology Co., Ltd.
The First Hospital of Jilin University

Recruiting

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG121 Tablets

Pharmacokinetics | Food Affect | Single Ascending Dose | Maximum Applicable Dose

China
Fujian Cosunter Pharmaceutical Co. Ltd

Unknown

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets

Hepatitis B

China
Beaujon Hospital

Unknown

Usefulness of Alpha-GST in Liver Transplantation (GST-LT)

Evidence of Liver Transplantation

France
Centre Hospitalier Universitaire Vaudois
Immutep S.A.S.

Terminated

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (LAG-3/IMP321)

Melanoma

Switzerland
STEBA France
STEBA LABORATORIES LTD.

Completed

Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers

Gastroesophageal Reflux | Esophagitis | Duodenal Ulcer | Stomach Ulcer

United States
Seoul National University Hospital

Completed

A Clinical Study to Explore Biomarkers for Drug-induced Liver Injury (DILI)

Healthy

Korea, Republic of
University Health Network, Toronto

Unknown

Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues (Stop)

Chronic Hepatitis B

Canada
Boehringer Ingelheim

Completed

Relative Bioavailability of BI 207127 Trial Formulation II Prototypes Versus BI 207127 Trial Formulation I in Healthy Volunteers

Healthy
Fujian Akeylink Biotechnology Co., Ltd.

Completed

Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver Function

COVID-19 Pneumonia

China
Baylor College of Medicine
Bill and Melinda Gates Foundation

Completed

Study of Na-ASP-2 Human Hookworm Vaccine in Healthy Adults Without Evidence of Hookworm Infection

Hookworm Infection

United States
LifeNet Health

Withdrawn

Devitalized Non-valved Pulmonary Artery Allograft Implant for the Repair of Congenital Cardiac Abnormalities

NA-Study Withdrawn
Changi General Hospital
National Taiwan University Hospital; Asan Medical Center

Completed

RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses

Pancreatic Diseases | Pancreatic Neoplasm

Singapore
Fujian Cosunter Pharmaceutical Co. Ltd

Unknown

Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161

Solid Tumor | C-Met Mutation-Related Tumors

China
Cedars-Sinai Medical Center
Johns Hopkins University; University of Alabama at Birmingham; University of... and other collaborators

Completed

Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study

Myocardial Ischemia

United States
Alcon Research

Completed

Kynex Versus Refresh Plus Study in Subject With Dry Eye

Dry Eye
Boehringer Ingelheim

Completed

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Hepatitis C, Chronic

United States, Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Switzerland, United Kingdom
Vanderbilt University Medical Center
Baxter Healthcare Corporation

Completed

Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2

End Stage Renal Disease

United States
Baylor College of Medicine
George Washington University

Completed

Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy Adults

Hookworm Infection | Hookworm Disease

United States
University College, London

Active, not recruiting

Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors (RECONCILE)

Prostate Cancer

United Kingdom
University of Manitoba

Unknown

Identifying a Sleep Screener for Disease Relapse in Children With Inflammatory Bowel Disease

IBD

Canada
University Hospital, Geneva
University of Geneva, Switzerland

Completed

Understanding COVID-19

SARS-CoV-2 Viral Kinetics and Host Immune Responses

Switzerland
King Khalid University

Unknown

Effect of Covid-19 Affliction on Psychological and Mental Health Among College Going Students: Cross-Sectional Survey

Covid19

Saudi Arabia
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 207127 NA in Healthy Male Asian Volunteers and Single Dose Study of BI 207127 NA in Healthy Male Caucasian Volunteers

Healthy

Korea, Republic of
Kresge Eye Institute

Suspended

Fluorescein Angiography With a Full-dose Versus a Half-dose of Intravenous Fluorescein

Fluorescein Angiography

United States
Onconova Therapeutics, Inc.

Completed

Safety of 24-Hour Infusion of ON 01910.Na in Patients With Advanced Cancer

Neoplasms | Cancer | Advanced Cancer | Solid Tumors

United States

Search clinical trials for: Na-GST-1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations